Matthias Reule

1.1k total citations
11 papers, 273 citations indexed

About

Matthias Reule is a scholar working on Molecular Biology, Cell Biology and Genetics. According to data from OpenAlex, Matthias Reule has authored 11 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cell Biology and 2 papers in Genetics. Recurrent topics in Matthias Reule's work include Microtubule and mitosis dynamics (3 papers), Acute Myeloid Leukemia Research (2 papers) and ATP Synthase and ATPases Research (2 papers). Matthias Reule is often cited by papers focused on Microtubule and mitosis dynamics (3 papers), Acute Myeloid Leukemia Research (2 papers) and ATP Synthase and ATPases Research (2 papers). Matthias Reule collaborates with scholars based in United Kingdom, Germany and Japan. Matthias Reule's co-authors include John F. Lyons, Neil T. Thompson, Lynsey Fazal, Jayne Curry, Hayley C. Angove, Nicola G. Wallis, Tomoko Smyth, Brent Graham, Ruth E. Feltell and David M. Cross and has published in prestigious journals such as Blood, Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Matthias Reule

11 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Reule United Kingdom 6 167 103 69 42 36 11 273
Jennifer Volkman United States 5 239 1.4× 111 1.1× 91 1.3× 33 0.8× 15 0.4× 9 365
Stacy M. Plum United States 8 200 1.2× 104 1.0× 78 1.1× 32 0.8× 18 0.5× 10 348
Mary Flanagan Quinn United States 6 284 1.7× 173 1.7× 43 0.6× 24 0.6× 19 0.5× 12 381
Tina Guthrie United States 6 241 1.4× 158 1.5× 40 0.6× 16 0.4× 32 0.9× 8 334
Anqun Tang China 5 243 1.5× 143 1.4× 137 2.0× 16 0.4× 21 0.6× 6 361
Victoria Lock United Kingdom 9 207 1.2× 187 1.8× 126 1.8× 18 0.4× 42 1.2× 11 353
Sreedhar Venkannagari United States 6 341 2.0× 97 0.9× 37 0.5× 115 2.7× 68 1.9× 8 415
Gina M. Ney United States 12 273 1.6× 82 0.8× 74 1.1× 58 1.4× 28 0.8× 19 438
Raffaella Pippa Spain 13 389 2.3× 121 1.2× 41 0.6× 85 2.0× 28 0.8× 20 480
Hanna Karvonen Finland 10 226 1.4× 105 1.0× 57 0.8× 16 0.4× 26 0.7× 13 332

Countries citing papers authored by Matthias Reule

Since Specialization
Citations

This map shows the geographic impact of Matthias Reule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Reule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Reule more than expected).

Fields of papers citing papers by Matthias Reule

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Reule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Reule. The network helps show where Matthias Reule may publish in the future.

Co-authorship network of co-authors of Matthias Reule

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Reule. A scholar is included among the top collaborators of Matthias Reule based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Reule. Matthias Reule is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Graham, Brent, Jayne Curry, Tomoko Smyth, et al.. (2011). The heat shock protein 90 inhibitor, AT13387, displays a long duration of action in vitro and in vivo in non‐small cell lung cancer. Cancer Science. 103(3). 522–527. 65 indexed citations
2.
Tanaka, Ruriko, Matthew Squires, Shinya Kimura, et al.. (2010). Activity of the multitargeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL–positive leukemic cells. Blood. 116(12). 2089–2095. 56 indexed citations
3.
Yap, Timothy A., Simon P. Heaton, Mike I. Walton, et al.. (2010). AT7867 Is a Potent and Oral Inhibitor of AKT and p70 S6 Kinase That Induces Pharmacodynamic Changes and Inhibits Human Tumor Xenograft Growth. Molecular Cancer Therapeutics. 9(5). 1100–1110. 50 indexed citations
4.
Lyons, John, Jayne Curry, Tomoko Smyth, et al.. (2009). Abstract A217: Comparison of long-term pharmacodynamic actions of the synthetic small molecule HSP90 inhibitor AT13387 in multiple xenograft models. Molecular Cancer Therapeutics. 8(12_Supplement). A217–A217. 2 indexed citations
5.
Curry, Jayne, Hayley C. Angove, Lynsey Fazal, et al.. (2009). Aurora B kinase inhibition in mitosis: Strategies for optimizing the use of Aurora kinase inhibitors such as AT9283. Cell Cycle. 8(12). 1921–1929. 41 indexed citations
6.
Howard, Steven, Valério Berdini, Jayne Curry, et al.. (2008). 287 POSTER Fragment-based discovery of AT9283; a multi-targeted kinase inhibitor with potent Aurora kinase activity. European Journal of Cancer Supplements. 6(12). 93–93. 3 indexed citations
7.
Lyons, John, Joseph Curry, Matthias Reule, et al.. (2008). 147 POSTER AT13387, a fragment derived clinical candidate is active in lung and melanoma models. European Journal of Cancer Supplements. 6(12). 47–47. 2 indexed citations
8.
Lyons, John F., Steven J. Woodhead, Ruth E. Feltell, et al.. (2007). AT13148, an orally bioavailable AKT kinase inhibitor with potent anti-tumor activity in both in vitro and in vivo models exhibiting AKT pathway deregulation.. Molecular Cancer Therapeutics. 6. 2 indexed citations
9.
Kasper, Grit, Matthias Reule, Miriam Tschirschmann, et al.. (2007). Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway. BMC Cancer. 7(1). 12–12. 44 indexed citations
10.
Squires, Matthew, Jayne Curry, Mark A. Dawson, et al.. (2007). AT9283, a Potent Inhibitor of JAK2, Is Active in JAK2 V617F Myeloproliferative Disease Models.. Blood. 110(11). 3537–3537. 6 indexed citations
11.
Gallagher, Neil J., John F. Lyons, Jayne Curry, et al.. (2006). Characterisation of aurora kinase inhibitors derived from fragment based lead discovery. Cancer Research. 66. 1155–1155. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Volkman Breakdown of academic impact, for papers by Stacy M. Plum Breakdown of academic impact, for papers by Mary Flanagan Quinn Breakdown of academic impact, for papers by Tina Guthrie Breakdown of academic impact, for papers by Anqun Tang Breakdown of academic impact, for papers by Victoria Lock Breakdown of academic impact, for papers by Sreedhar Venkannagari Breakdown of academic impact, for papers by Gina M. Ney Breakdown of academic impact, for papers by Raffaella Pippa Breakdown of academic impact, for papers by Hanna Karvonen
Rankless by CCL
2026